Cuba teams with China's Lukang to manufacture biotech products; Catalent, BASF take on solubility challenges;

> Cuba's Center for Genetic Engineering and Biotechnology and Lukang Pharmaceutical in China announced plans to cooperatively manufacture and market biotechnology products. Item

> Catalent and BASF will jointly market technology to address drug solubility issues to help companies formulate optimal dose form from development through scale-up and supply. Story

> Nepal's Department of Drug Administration is writing good manufacturing practice (GMP) regulations that will meet World Health Organization (WHO) standards in expectation of raising drug manufacturing standards and making the country's pharmaceuticals more acceptable internationally. Article

> US Pharmacopeia (USP) is investing $1.5 million and looking for donors to set up a facility which will fund itself offering quality control services to pharmaceutical manufacturers in Sub-Saharan Africa. Story

> Omkar Specialty Chemicals in India has acquired LASA Laboratory, which has an API manufacturing facility that makes mostly active ingredients for veterinary pharmaceuticals. More

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.